February 27, 2020

Hospital Infection Prevention And Control Market Is Expected To Reach US$ 245.6 Mn By 2024

The latest market report published by Credence Research, Inc. “Hospital Infection Prevention and Control Market – Growth, Future Prospects, and Competitive Analysis, 2016 – 2024,” the global hospital infection prevention and control market was valued at US$ 142.6 million in 2015 and is expected to reach US$ 245.6 million by 2024, increasing to CAGR by 6.3 per cent from 2016 to 2024.

Market Insights

Market experts suggest that health-related infections are a costly issue facing many hospitals around the globe. Hospital-acquired infections are a type of infection that is observed in patients with unrelated conditions during treatment. According to the World Health Organization (WHO), infectious waste contributes to the risk of nosocomial infections, putting hospital personnel and patients at risk. The Centers for Disease Control and Prevention (CDC) statistically suggested that, with approximately 300,000 occurrences per year, surgical site infections (SSIs) are the second most prevalent HAI in the United States, preceded only by urinary tract infections. At a cost of approximately US$ 10 billion annually, this high incidence of SSIs has a significant impact on the U.S. healthcare system as well as on the bottom line of individual hospitals.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/hospital-infection-prevention-and-control-market

We have seen the occurrence of nosocomial infections worldwide in both developed and resource-poor countries. The key factors contributing to the growth of the hospital infection prevention and control market are increasing prevalence of infections, the implementation of strict guidelines for the prevention and control of hospital infections, the development of healthcare infrastructure in emerging countries and an increasing number of hospitals around the world.

The global hospital infection prevention and control market are segmented by type of infection such as pneumonia, urinary tract infection, bloodstream infection, surgical site infection, MRSA and others. These are the major types of hospital-acquired infections that have the highest prevalence. As a source of CDC, ventilator-associated pneumonia and surgical site infection are the most common conditions followed by GI, UTI, and primary bloodstream infections.

Global Hospital Infection Prevention and Control Markets are segmented by product type as Infection Prevention Supplies, Infection Prevention Equipment, and Infection Prevention Services. Infection prevention supplies held the largest share in the overall market for the prevention and control of hospital infections.

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58360

Based on the therapeutic application type, the global hospital infection prevention and control market is segmented as follows:

  • Infection Prevention Supplies
    • Disinfectants
    • Protective Apparel & Textiles
    • Safety-Enhanced Medical Devices
    • Sterilization Supplies
    • Medical Waste Disposal Supplies
  • Infection Prevention Equipment
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Washing/Disinfecting Equipment
    • Other Infection Prevention Equipment
  • Infection Prevention Services
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Washing/Disinfecting Equipment
    • Other Infection Prevention Equipment

As of the current market scenario, North America formed the largest market for hospital infection prevention and control market due to the rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians, and caregivers aligning with regulatory bodies. Asia Pacific is the fastest-growing segment with an increase in awareness of the healthcare-associated infection, rising investment in health care infrastructure, technological advancement and new protocols and programs conducted for infection prevention and control in line with WHO guidelines.

Market Competition Assessment:

Key players in the Hospital Infection Prevention Control market are

3M Company, Ansell Ltd., Becton, Dickinson and Company, Belimed AG, Bemis Company, Inc., B. Braun Melsungen AG, Cantel Medical Corp., Cantel Medical Corp., Covidien plc, Crosstex International, Inc., Danaher Corp., Diversey, Inc., Getinge Group, Johnson & Johnson, Halyard Health, Inc., MMM Group, Matachana Group, Medivators, Inc., Purdue Pharma LP, Sealed Air Corp, Semperit AG Holding, Synergy Health plc, and Terumo Corp.

Key Market Movements:

  • Hospital-acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries. Nosocomial infection is a major cause of concern for the patient and as well as the health care providers. The rising prevalence of nosocomial infection is a major driving factor for hospital infection and the prevention market.
  • WHO and various other regulatory bodies at the regional and national levels provide guidelines for hospital infection prevention and control. The significant steps taken to control infection include identifying patients at risk of nosocomial infection, maintaining hand hygiene, practicing standard precautionary measures to reduce the transmission and applying novel strategies to reduce VAP, CR-BSI, and CAUTI.
  • In Emerging economies, there is a rise in R&D and increase government initiative in the health care sector. There has been the introduction of key corporate hospital chains, which play a major role in driving the growth and the expansion of the healthcare sector. With this rise in the number of hospitals increases the chances of nosocomial infection.

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58360

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Market Segmentation

By Product Type

  • Infection Prevention Supplies
    • Disinfectants
    • Protective Apparel & Textiles
    • Safety-Enhanced Medical Devices
    • Sterilization Supplies
    • Medical Waste Disposal Supplies
  • Infection Prevention Equipment
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Washing/Disinfecting Equipment
    • Other Infection Prevention Equipment
  • Infection Prevention Services
    • Medical Waste Disposal Services
    • Contract Sterilization Services
    • Infection Prevention Equipment
    • Infection Prevention Services

By Infection Type

  • Pneumonia
  • Urinary Tract Infection
  • Blood Stream Infection
  • Surgical Site Infection
  • MRSA
  • Others

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58360

Leave a Reply

Your email address will not be published. Required fields are marked *